Burns Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Burn Pipeline Drugs Market
A Burn is damage to body’s tissues caused by heat, chemicals, electricity, sunlight or radiation. Symptoms include pain, increasing with each degree of burn, red and swollen skin, blisters and charred and blackened skin. Treatment includes antibiotics and pain relievers.
The Burn – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Burn, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Burn and features dormant and discontinued projects.
Key Targets in the Burn Pipeline Drugs Market
The key targets in the Burn pipeline drugs market are Bacterial Cell Wall, Epidermal Growth Factor Receptor, Adenosine Receptor, Alkaline Phosphatase, Bacterial Cell Membrane, and Cannabinoid Receptor 2 among others.
Burn Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Burn Pipeline Drugs Market
The key mechanisms of action in the Burn pipeline drugs market are Bacterial Cell Wall Disruptor, Epidermal Growth Factor Receptor Agonist, Adenosine Receptor Inhibitor, Alkaline Phosphatase Replacement, Bacterial Cell Membrane Disruptor, Free Radical Scavenger, and Interleukin 6 Inhibitor.
Burn Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Burn Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Burn pipeline drugs market are Topical, Subcutaneous, Intravenous, Oral, Inhalational, Nasal, Ophthalmic, and Parenteral among others.
Burn Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Burn Pipeline Drugs Market
The key molecule types in the Burn pipeline drugs market are Enzyme, Small Molecule, Peptide, Fusion Protein, Cell Therapy, Synthetic Peptide, and Biologic among others.
Burn Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Burn Pipeline Drugs Market
The major companies in the Burn pipeline drugs market are MediWound Ltd, Bioharmony Therapeutics Inc, AlgiPharma AS, Alliance Pharma Plc, Biomendics LLC, Clene Inc, AlgiPharma AS, Anterogen Co Ltd, Claritas Pharmaceuticals Inc, and GNT Pharma Co Ltd among others.
Burn Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Burn Pipeline Drugs Market Overview
| Key Targets | Bacterial Cell Wall, Epidermal Growth Factor Receptor, Adenosine Receptor, Alkaline Phosphatase, Bacterial Cell Membrane, and Cannabinoid Receptor 2 |
| Key Mechanisms of action | Bacterial Cell Wall Disruptor, Epidermal Growth Factor Receptor Agonist, Adenosine Receptor Inhibitor, Alkaline Phosphatase Replacement, Bacterial Cell Membrane Disruptor, Free Radical Scavenger, and Interleukin 6 Inhibitor |
| Key Routes of Administration | Topical, Subcutaneous, Intravenous, Oral, Inhalational, Nasal, Ophthalmic, and Parenteral |
| Key molecule types | Enzyme, Small Molecule, Peptide, Fusion Protein, Cell Therapy, Synthetic Peptide, and Biologic |
| Major companies | MediWound Ltd, Bioharmony Therapeutics Inc, AlgiPharma AS, Alliance Pharma Plc, Biomendics LLC, Clene Inc, AlgiPharma AS, Anterogen Co Ltd, Claritas Pharmaceuticals Inc, and GNT Pharma Co Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Burn
- The pipeline guide reviews pipeline therapeutics for Burn by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Burn therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Burn therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Burn
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Burn
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Burn pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Aegle Therapeutics Corp
AlgiPharma AS
Alliance Pharma Plc
Alloksys Life Sciences BV
Amniotics AB
Anterogen Co Ltd
Bioharmony Therapeutics Inc
Biomendics LLC
CFM Pharma Holding BV
Chrysalis BioTherapeutics Inc
Claritas Pharmaceuticals Inc
Clene Inc
cStem Regeneration Pharmaceutical Co Ltd
Energenesis Biomedical Co Ltd
FirstString Research Inc
FortuneRock (China) Ltd
GNT Pharma Co Ltd
Hunan Sanqing Pharmaceutical Co Ltd
Hypo-Stream Ltd
Imagine Pharma LLC
Jupiter Wellness Inc
Kala Pharmaceuticals Inc
Madam Therapeutics BV
Marizyme Inc
Maxwell Biosciences Inc
MediWound Ltd
MicroCures Inc
NeoMatrix Therapeutics Inc
NextPhase Therapeutics
Oxacell AG
Phagelux Inc
Pharmaxis Ltd
QBiotics Group Ltd
Recce Pharmaceuticals Ltd
Regeneus Ltd
Rejuvenation Technologies Inc
Riptide Bioscience Inc
Se-cure Pharmaceuticals Ltd
Shulov Innovative Science Ltd
Stemsynergy Therapeutics Inc
TGV-Inhalonix Inc
Theragnostic Technologies Inc
TreeFrog Therapeutics SAS
USV Pvt Ltd
viDA Therapeutics Inc
Washburn Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Burn pipeline drugs market?
The key targets in the Burn pipeline drugs market are Bacterial Cell Wall, Epidermal Growth Factor Receptor, Adenosine Receptor, Alkaline Phosphatase, Bacterial Cell Membrane, and Cannabinoid Receptor 2.
-
What are the key mechanisms of action in the Burn pipeline drugs market?
The key mechanisms of action in the Burn pipeline drugs market are Bacterial Cell Wall Disruptor, Epidermal Growth Factor Receptor Agonist, Adenosine Receptor Inhibitor, Alkaline Phosphatase Replacement, Bacterial Cell Membrane Disruptor, Free Radical Scavenger, and Interleukin 6 Inhibitor.
-
What are the key routes of administration in the Burn pipeline drugs market?
The key routes of administration in the Burn pipeline drugs market are Topical, Subcutaneous, Intravenous, Oral, Inhalational, Nasal, Ophthalmic, and Parenteral.
-
What are the key molecule types in the Burn pipeline drugs market?
The key molecule types in the Burn pipeline drugs market are Enzyme, Small Molecule, Peptide, Fusion Protein, Cell Therapy, Synthetic Peptide, and Biologic.
-
What are the major companies in the Burn pipeline drugs market?
The major companies in the Burn pipeline drugs market are MediWound Ltd, Bioharmony Therapeutics Inc, AlgiPharma AS, Alliance Pharma Plc, Biomendics LLC, Clene Inc, AlgiPharma AS, Anterogen Co Ltd, Claritas Pharmaceuticals Inc, and GNT Pharma Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Dermatology reports